Home>Mutual Funds>Nippon India Mutual Fund>Nippon India Pharma Fund Growth
shareSHARE

Nippon India Pharma Fund Growth+1.75%

62.78%
1 Year Return
Equity
Sectoral/Thematic
5.0star
6M
1Y
3Y
5Y
All

Fund Details

Nippon India Pharma Fund Growth

RiskHigh
Min SIP Amount₹100
Expense Ratio2.02%
NAV₹255.49 (25 Jan 2021)
Fund Started05 Jun 2004
Fund Size4,383 Cr

Returns

1Y
3Y*
5Y*
Since inception*
Fund Returns
62.8%
20.2%
13.2%
18.6%
Category Average
59.0%
17.4%
9.8%
-
Rank Within Category
3
1
1
-
*All returns are annualized.
SIP
ONE TIME
Minimum SIP amount100
Amount Per Month₹5,000
Duration
1Y back
3Y back
5Y back
Would have become
0
with 62.8% returns per annum

Comparison

Data not available
Pros
1. Age is more than 10 years
2. Risk is lower compared to the benchmark
3. 1Y Returns are higher than the benchmark
4. 3Y Returns are higher than the benchmark
5. 5Y Returns are higher than the benchmark
6. Age is more than 10 years
7. 3Y Returns are higher than the category average returns
8. 5Y Returns are higher than the category average returns
9. 10Y Returns are higher than the category average returns
Cons
1. Risk-adjusted returns are lower compared to the category
2. Higher expense ratio
3. 10Y Returns are lower than the benchmark
4. Risk-adjusted returns are lower compared to the category
5. Higher expense ratio - 2.19%
6. 1Y Returns are lower than the category average returns

Top Holdings

NameSectorInstrument% Assets
Sun Pharmaceutical Inds. Ltd.HealthcareEquity10.8%
Aurobindo Pharma Ltd.HealthcareEquity10.5%
Cipla Ltd.HealthcareEquity9.3%
Divi's Laboratories Ltd.HealthcareEquity9.2%
Dr. Reddy's Laboratories Ltd.HealthcareEquity8.9%
Lupin Ltd.HealthcareEquity8.9%
Cadila Healthcare Ltd.HealthcareEquity6.5%
Fortis Healthcare (India) LtdHealthcareEquity5.7%
Gland Pharma Ltd.HealthcareEquity4.3%
Thyrocare Technologies Ltd.HealthcareEquity4.3%
See All

Fund Managers

Sailesh Raj Bhan
keyboard_arrow_down

Nippon India Pharma Fund Growth Details

Nippon India Pharma Fund Growth is a Equity Mutual Fund Scheme launched by Nippon India Mutual Fund. This scheme was made available to investors on 05 Jun 2004. Sailesh Raj Bhan is the Current Fund Manager of Nippon India Pharma Fund Growth fund.The fund currently has an Asset Under Management(AUM) of ₹4,383 Cr and the Latest NAV as of 25 Jan 2021 is ₹255.49.

The Nippon India Pharma Fund Growth is rated High risk. Minimum SIP Investment is set to 100. Minimum Lumpsum Investment is 5000. Exit load of 1% if redeemed within 1 month.

Investment Objective

The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Tax Implications

Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.

Scheme Information Document(SID)

₹5000
Min for First Investment
₹1000
Min for Second Investment
Exit load of 1% if redeemed within 1 month.
Exit Load

Compare Funds

Nippon India Pharma Fund Growth
VS
search

About Nippon India Mutual Fund

Address
Corporate Office : Reliance Centre, 7th Floor South Wing, OFf Western Express Highway, Santacruz(E) Mumbai-400055
Phone
022-33031000/30301111
Launch Date
30 Jun 1995
Nippon India Mutual Fund
Asset Management Company
Custodian
Deutsche Bank
Registrar & Transfer Agent
KFin Tech
Address
Karvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills,
Similar Funds